Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ciernik, I. F.
Right arrow Articles by Lutolf, U. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ciernik, I. F.
Right arrow Articles by Lutolf, U. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 12, 1484-1490, Copyright © 1994 by American Society of Clinical Oncology


ARTICLES

Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy

IF Ciernik, U Meier and UM Lutolf
Department of Radiology, University Hospital, Zurich, Switzerland.

BACKGROUND: Stage III and stage IV thymomas with significant macroscopic infiltration to the neighboring structures are rarely completely resectable. It therefore remains unclear to what extent tumors must be surgically debulked to improve prognosis. PATIENTS AND METHODS: We reviewed the cases of 31 patients with incompletely resected invasive thymoma and residual macroscopic disease who were referred to postoperative irradiation. Survival and local tumor control were analyzed. All patients were treated between 1958 and 1990 with megavoltage irradiation at doses ranging from 42 to 66 Gy. The shortest follow-up time for living patients was more than 5 years. RESULTS: The overall median 5-year survival rate was 45%. Eighteen stage III patients had a 5-year survival rate of 61% and a 10-year survival rate of 57%. Thirteen patients had stage IV disease and 5- and 10-year survival rates of 23% and 8%, respectively. Univariate and multivariate analyses confirmed a worse prognosis for stage IV disease. Epithelial or spindle-cell thymoma was associated with stage IV disease. Twenty- two percent of patients with stage III disease had epithelial or spindle-cell thymoma, versus 69% of patients with stage IV disease (P = .02 for univariate and P = .05 for multivariate analysis). Initial tumor diameter greater than 10 cm correlated with poor prognosis in the univariate analysis (P = .05). However, more importantly, debulking of tumor did not significantly improve outcome when compared with patients who received biopsy only. The median survival rate of patients with stage IVa disease did not differ from that of those with stage IVb disease. Mediastinal control was achieved in 23 patients (74%). Stage IV disease did not correlate with an increase in local treatment failure after irradiation, although epithelial or spindle-cell thymoma predisposed for local treatment failure (46% v 11%; P = .04 in univariate and P = .055 in multivariate analysis). CONCLUSION: Tumor debulking leaving macroscopic residual thymoma, as opposed to biopsy alone, does not improve prognosis when followed by radiation. Radiation therapy for local tumor control is most effective in nonepithelial- predominant thymomas.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
In VivoHome page
V. VASSILIOU, A. TSAMANDAS, N. KATODRITIS, N. CHAROULIS, A. KOUKOUMA, D. ANDREOPOULOS, S. SALAKOU, V. ZOLOTA, P. PAPATHANASSOPOULOS, G. CHRISTODOULIDES, et al.
The Role of Postoperative Radiotherapy in the Management of Patients with Thymic Tumors -- A Retrospective Study
In Vivo, September 1, 2009; 23(5): 843 - 852.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. D. Wright, P. Fidias, N. C.H. Choi, J.-A. O. Shepard, and R. P. Hasserjian
Case 16-2007 -- A 61-Year-Old Man with a Mediastinal Mass
N. Engl. J. Med., May 24, 2007; 356(21): 2185 - 2193.
[Full Text] [PDF]


Home page
The OncologistHome page
R. F. Riedel and W. R. Burfeind Jr
Thymoma: Benign Appearance, Malignant Potential
Oncologist, September 1, 2006; 11(8): 887 - 894.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. C. Detterbeck and A. M. Parsons
Thymic tumors
Ann. Thorac. Surg., May 1, 2004; 77(5): 1860 - 1869.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. B. Johnson, T. Y. Eng, G. Giaccone, and C. R. Thomas Jr.
Thymoma: Update for the New Millenium
Oncologist, June 1, 2001; 6(3): 239 - 246.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. R. Thomas, C. D. Wright, and P. J. Loehrer
Thymoma: State of the Art
J. Clin. Oncol., July 1, 1999; 17(7): 2280 - 2280.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. Bacha, A. R. Chapelier, P. Macchiarini, E. Fadel, and P. G. Dartevelle
Surgery for invasive primary mediastinal tumors
Ann. Thorac. Surg., July 1, 1998; 66(1): 234 - 239.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Fujino, N. Tezuka, S. Watarida, K. Katsuyama, S. Inoue, and A. Mori
Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion
Ann. Thorac. Surg., July 1, 1998; 66(1): 263 - 264.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Yagi, T. Hirata, T. Fukuse, H. Yokomise, K. Inui, O. Ike, H. Mizuno, M. Aoki, S. Hitomi, and H. Wada
Surgical Treatment for Invasive Thymoma, Especially When the Superior Vena Cava Is Invaded
Ann. Thorac. Surg., February 1, 1996; 61(2): 521 - 524.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
D. Blumberg, J. L. Port, B. Weksler, R. Delgado, J. Rosai, M. S. Bains, R. J. Ginsberg, N. Martini, P. M. McCormack, V. Rusch, et al.
Thymoma: A Multivariate Analysis of Factors Predicting Survival
Ann. Thorac. Surg., October 1, 1995; 60(4): 908 - 913.
[Abstract] [Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1994 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online